Results summary | View all lists in GO:BiolProc | View all genes in D07AB.profile.ud50 |
anatomical structure development The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome. enrichment: 1.57-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
215073_S_AT | NR2F2 | D | E | R | S | nuclear receptor subfamily 2, group F, member 2 | |||||||
204334_AT | KLF7 | D | R | Kruppel-like factor 7 (ubiquitous) | |||||||||
207499_X_AT | UNC45A | D | P | unc-45 homolog A (C. elegans) | |||||||||
203140_AT | BCL6 | G | D | X | R | C | S | B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||||
207826_S_AT | ID3 | D | R | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | |||||||||
213139_AT | SNAI2 | D | R | C | snail homolog 2 (Drosophila) | ||||||||
212501_AT | CEBPB | G | D | X | P | R | CCAAT/enhancer binding protein (C/EBP), beta | ||||||
34697_AT | LRP6 | T | D | S | low density lipoprotein receptor-related protein 6 | ||||||||
209357_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
209185_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
219884_AT | LHX6 | D | R | LIM homeobox 6 | |||||||||
207980_S_AT | CITED2 | D | R | S | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | ||||||||
202936_S_AT | SOX9 | D | R | C | SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal sex-reversal) | ||||||||
209099_X_AT | JAG1 | G | D | S | jagged 1 (Alagille syndrome) | ||||||||
218559_S_AT | MAFB | D | R | v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) | |||||||||
205926_AT | IL27RA | D | X | S | interleukin 27 receptor, alpha | ||||||||
201502_S_AT | NFKBIA | G | T | D | S | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |||||||
201341_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) | ||||||||||
208961_S_AT | KLF6 | D | R | S | Kruppel-like factor 6 | ||||||||
210355_AT | PTHLH | G | D | C | S | parathyroid hormone-like hormone | |||||||
209184_S_AT | IRS2 | G | D | E | S | insulin receptor substrate 2 | |||||||
205032_AT | ITGA2 | D | X | C | S | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |